Medicine and Dentistry
Spinal Cord Injury
100%
Zoledronic Acid
100%
Therapeutic Procedure
100%
Placebo
100%
Bone Density
66%
Serum
50%
Osteolysis
50%
Bone
50%
Patient
33%
Inpatient
33%
Hip
33%
Group Trial
16%
Alkaline Phosphatase
16%
Tertiary Care
16%
Amino Terminal Sequence
16%
Rehabilitation Engineering
16%
Femoral Neck
16%
Procollagen
16%
Collagen Type 1
16%
Absorptiometry
16%
American Spinal Injury Association Impairment Scale
16%
Telopeptide
16%
Hospital
16%
Amaurosis
16%
Knee
16%
Nursing and Health Professions
Spinal Cord Injury
100%
Placebo
100%
Zoledronic Acid
100%
Bone Density
66%
Marker
50%
Randomization
16%
Tertiary Health Care
16%
Blood Level
16%
Rehabilitation Engineering
16%
Hospital
16%
American Spinal Injury Association Impairment Scale
16%
Alkaline Phosphatase
16%
Sample
16%
Blindness
16%
Telopeptide
16%
Collagen Type 1
16%
Procollagen
16%
Absorptiometry
16%
INIS
bones
100%
injuries
100%
spinal cord
100%
patients
66%
bone mineral density
66%
losses
50%
levels
33%
design
16%
x radiation
16%
hospitals
16%
collagen
16%
bone joints
16%
alkaline phosphatase
16%
Neuroscience
Spinal Cord Injury
100%
Zoledronic Acid
100%
Placebo
100%
Amino Terminal Sequence
16%
Collagen Type 1
16%
Procollagen
16%
Alkaline Phosphatase
16%
Telopeptide
16%
Pharmacology, Toxicology and Pharmaceutical Science
Spinal Cord Injury
100%
Zoledronic Acid
100%
Mineral
66%
Alkaline Phosphatase
16%
Spine Injury
16%
Collagen Type 1
16%
Procollagen
16%
Telopeptide
16%
Blindness
16%